Rising demand for gene and cell therapies, expanding mRNA vaccine pipelines, and increasing investments in GMP-compliant manufacturing facilities are driving growth in the viral vectors and plasmid ...
This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...
By Henry A. Onwubiko“A nation that cannot control its own seeds cannot decide its destiny.” –Captain Ibrahim Troure Genetic engineering, the manipulation of deoxyribonucleic acid (DNA), the hereditary ...
We report here the construction of a vector derived from pET3-His and pRSET plasmids for the expression and purification of recombinant proteins in Escherichia coli based on T7 phage RNA polymerase.
This article explores limitations of chemical synthesis in high-throughput settings and the technical advantages enzymatic ...
AAV-based gene therapies hold promise for treating disease, but their long-lasting gene expression limits their use in regenerative medicine. A study now presents DreAM, a drug-inducible AAV system ...
Synthetic Biology Group, J. Craig Venter Institute, La Jolla, California 92037, United States Department of Bioengineering, University of California, San Diego, La Jolla, California 92093, United ...
The Drosophila Gateway™ Vector collection is a set of 68 Gateway-based vectors designed to express epitope-tagged proteins in Drosophila culture cells or flies. At its core is Invitrogen's Gateway™ ...
This study reports a valuable method to predict the capacity of a candidate probiotic bacterium to metabolically outcompete a bacterial pathogen in the ecological niche of the murine respiratory tract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback